All posts by: Michael Zand

About Michael Zand

Northern Ireland student spent days in London donating stem cells to save stranger’s life – Belfast Telegraph

Continue reading

2017-11-01 NEWS

Belfast Telegraph

Northern Ireland student spent days in London donating stem cells to save stranger’s life
Belfast Telegraph
“Throughout various placements within hospitals, I had seen first-hand the devastating effect that blood cancer can have on people – the difficulties that can occur in finding a match for a stem cell transplant and the life-changing effect that a

and more »

Continue reading

2017-11-01 NEWS

Vedanta Biosciences to Advance Cancer Immunotherapy Candidates Based on Microbiome-Derived Live …
Business Wire (press release)
“Dr. Honda’s research suggests an entirely new approach to cancer immunotherapy harnessing the human microbiome, which has the potential to significantly enhance the effectiveness of cancer therapies,” said Bernat Olle, PhD, Chief Executive Officer of …

and more »

Continue reading

2017-11-01 NEWS

Xconomy

Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s
Xconomy
A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson’s disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal. Global rights to Parkinson’s treatment VY-AADC01 …
Sanofi walks away from Voyager’s phase 2/3 Parkinson’s gene therapyBSA bureau (press release)

all 2 news articles »

Continue reading

2017-11-01 NEWS

Xconomy

Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s
Xconomy
A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson’s disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal. Global rights to Parkinson’s treatment VY-AADC01 …
Sanofi walks away from Voyager’s phase 2/3 Parkinson’s gene therapyBSA bureau (press release)

all 2 news articles »

Continue reading

2017-11-01 NEWS

Xconomy

Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s
Xconomy
A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson’s disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal. Global rights to Parkinson’s treatment VY-AADC01 …
Sanofi walks away from Voyager’s phase 2/3 Parkinson’s gene therapyBSA bureau (press release)

all 2 news articles »

Continue reading

2017-11-01 NEWS

Alabama’s News Leader

Chelsea clinic introduces oral immunotherapy for nut allergies
Alabama’s News Leader
Last year, Laura started oral immunotherapy treatment to help desensitize her allergy to tree nuts. “This offers the therapy that allows them to get the food back in the diet safely, as long as it’s continued,” said Dr. Carolyn Comer, Medical Director

and more »

Continue reading

2017-11-01 NEWS

Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017
Nasdaq
SYDNEY, Australia, Oct. 31, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer and Medical Officer, gave an oral presentation at the World …

and more »